A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt/mTOR Signaling and Induction of Autophagy

Overview of attention for article published in Molecular Cancer Therapeutics, May 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

patent: 11 patents

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 11 patents that reference this research output.

American Association for Cancer Research

Article Metrics

A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt/mTOR Signaling and Induction of Autophagy

About this Attention Score

Mentioned by

Citations

Readers on

American Association for Cancer Research

Article Metrics

A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt/mTOR Signaling and Induction of Autophagy

About this Attention Score

Mentioned by

Citations

Readers on

Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses

Grant US-11680073-B2

United States of America

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

Grant US-11407727-B2

United States of America

Method of treating or preventing Ras-mediated diseases

Grant US-11198679-B2

United States of America

Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses

Grant US-11186596-B2

United States of America

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

Grant US-11130744-B2

United States of America

Method of treating or preventing Ras-mediated diseases

Grant US-11104658-B2

United States of America

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

Grant US-10981886-B2

United States of America

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

Grant US-10975054-B2

United States of America

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

Grant US-10526307-B2

United States of America

Method of selectively inhibiting Ras-mediated tumor growth in humans

Application US-9931315-B2

United States of America

Indenyl compounds, pharmaceutical compositions, and medical uses thereof

Grant US-9862698-B2

United States of America